Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-04 Tanguler Tolga EVP, Chief Commercial Officer Sale −106 $319.03 $34K 36,500
2026-03-04 Tanguler Tolga EVP, Chief Commercial Officer Sale −102 $320.01 $33K 36,398
2026-03-04 Tanguler Tolga EVP, Chief Commercial Officer Sale −215 $320.81 $69K 36,183
2026-03-04 Tanguler Tolga EVP, Chief Commercial Officer Sale −289 $321.82 $93K 35,894
2026-03-04 Tanguler Tolga EVP, Chief Commercial Officer Sale −350 $323.01 $113K 35,544
2026-03-04 Tanguler Tolga EVP, Chief Commercial Officer Sale −767 $323.84 $248K 34,777
2026-03-04 Tanguler Tolga EVP, Chief Commercial Officer Sale −272 $324.88 $88K 34,505
2026-03-04 Tanguler Tolga EVP, Chief Commercial Officer Sale −208 $325.67 $68K 34,297
2026-03-04 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −29 $319.03 $9K 21,831
2026-03-04 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −28 $320.01 $9K 21,803
2026-03-04 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −59 $320.81 $19K 21,744
2026-03-04 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −79 $321.82 $25K 21,665
2026-03-04 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −96 $323.01 $31K 21,569
2026-03-04 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −210 $323.84 $68K 21,359
2026-03-04 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −75 $324.88 $24K 21,284
2026-03-04 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −57 $325.67 $19K 21,227
2026-03-03 Garg Pushkal EVP Chief R&D Sale 10b5-1 −355 $316.74 $112K 24,826
2026-03-03 Garg Pushkal EVP Chief R&D Sale 10b5-1 −317 $319.06 $101K 24,509
2026-03-03 Garg Pushkal EVP Chief R&D Sale 10b5-1 −640 $320.48 $205K 23,869
2026-03-03 Garg Pushkal EVP Chief R&D Sale 10b5-1 −463 $321.50 $149K 23,406

Page 5 of 41 · 816 trades